Loading organizations...
DNA methylation-based tumor categorization solutions.
Heidelberg Epignostix has raised $4.7M across 1 funding round.
Heidelberg Epignostix has raised $4.7M in total across 1 funding round.
Heidelberg Epignostix has raised $4.7M in total across 1 funding round.
Heidelberg Epignostix's investors include Carma Fund.
Heidelberg Epignostix has raised $4.7M across 1 funding round. Most recently, it raised $4.7M Seed in July 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 8, 2024 | $4.7M Seed | Carma Fund |